Dg Capital Management, LLC Biocryst Pharmaceuticals Inc Transaction History

Dg Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$9.5 - $17.24 $1.93 Million - $3.51 Million	-203,337 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$7.37 - $13.61 $2.47 Million - $4.55 Million	-334,529 Reduced 62.2%	203,337 $2.07 Million
Q4 2020 Feb 12, 2021	SELL	$3.37 - $8.61 $2.19 Million - $5.59 Million	-648,860 Reduced 54.68%	537,866 $4.01 Million
Q3 2020 Nov 16, 2020	BUY	$3.43 - $5.53 $146,227 - $235,754	42,632 Added 3.73%	1,186,726 $4.08 Million
Q2 2020 Aug 13, 2020	BUY	$1.9 - $5.61 $2.17 Million - $6.42 Million	1,144,094 New	1,144,094 $5.45 Million

279

172M

625K

739K

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.41B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

Get notified when there are updates to the investment portfolio of Dg Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Dg Capital Management, LLC with notifications on news.